Liquid crystalline medium

Liquid crystal medium (Q) comprises one or more fluoro-substituted-benzene compound (I). Liquid crystal medium (Q) comprises one or more fluoro-substituted-benzene compound of formula (I). R 0> : 1-15C-alkyl- or alkoxy, where one or more CH 2 groups are substituted by C?=C, CF 2O, CH=CH, cyclobut...

Full description

Saved in:
Bibliographic Details
Main Authors CZANTA, MARKUS DR, HIRSCHMANN, HARALD DR, WITTECK, MICHAEL DR, REIFFENRATH, VOLKER
Format Patent
LanguageEnglish
French
German
Published 19.12.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Liquid crystal medium (Q) comprises one or more fluoro-substituted-benzene compound (I). Liquid crystal medium (Q) comprises one or more fluoro-substituted-benzene compound of formula (I). R 0> : 1-15C-alkyl- or alkoxy, where one or more CH 2 groups are substituted by C?=C, CF 2O, CH=CH, cyclobutane-1,3-yl, spiro[3.3]heptane-2,6-yl, O, CO-O or OCO, the O atoms are not directly connected and one or more hydrogen atoms are substituted by halo; L 1> : H or F (preferred); n : 1 or 2 (preferred); and ring A, ring B : 2-fluoro-benzene-1,4-yl, 1,3-difluoro-benzene-2,5-yl (both preferred), cyclohexane-1,4-yl, benzene-1,4-yl. Independent claims are included for: (1) the new or known fluoro-substituted-benzene compound (I); and (2) the preparation of (Q) comprising mixing (I) with one or more benzene compound of formula (II) or (XXVII), dibenzene compound of formula (III)-(VIII), fluoro-substituted dibenzene compound of formula (X) or (XI), tri-benzene compound of formula (XII)-(XV), difluoro-substituted tetrabenzene compound of formula (XXI) or (XXII) and liquid crystalline compounds and/or additives. Ring C : 1,4-phenyl or trans-1,4-cyclohexyl; a : 0 or 1; R 3> : 2-9C-alkenyl, preferably R3a-CH=CH- or R3a-CH=CH-CH 2-CH 2-; R 4> : R 0>, preferably R4a-CH=CH- or R4a-CH=CH-CH 2-CH 2-; R3a, R4a : H, CH 3, C 2H 5 or C 3H 7; Y 1>-Y 4> : H o F; X 0> : F, Cl, CN, SF 5, SCN, NCS, halogenated up to 6C-alkyl, -alkenyl, -alkoxy or -alkenyloxy; Z 0> : C 2H 4, (CH 2)4, CH=CH, CF=CF, C 2F 4, CH 2CF 2, CF 2CH 2, CH 2O, OCH 2, COO, CF 2O or OCF 2; r : 0 or 1; ring D, ring E : cyclohexane-1,4-yl, tetrahydro-pyran-2,5-yl or [1,3]dioxane-2,5-yl; and R 1>, R 2> : 2-9C- n-alkyl, -alkoxy, -oxaalkyl, -fluoroalkyl or -alkenyl. Provided that: both the ring D and E are not simultaneously cyclohexyl. In formula (V), (VI): Z 0> : CF 2O, COO (both preferred), C 2H 4, (CH 2)4, CH=CH, CF=CF, C 2F 4, CH 2CF 2, CF 2CH 2, CH 2O, OCH 2, OCF 2 or a bond. [Image] [Image] [Image] [Image] [Image] [Image].
Bibliography:Application Number: EP20110002583